v3.22.2.2
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-controlling Interests
Series A Convertible Preferred Stock
Preferred Stock
Balances (in Shares) at Dec. 31, 2020   26,162,122         16,789,088
Balances at Dec. 31, 2020 $ (880,710) $ 2,616 $ 19,650,659 $ (77,841) $ (20,457,823) $ 0 $ 1,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Conversion of shares due to merger capitalization (in Shares)   (17,039,126)         (16,789,088)
Conversion of shares due to merger capitalization 0 $ (1,704) 3,383       $ (1,679)
Balances, as previously reported and effect of reverse recapitalization (in Shares)   9,122,996          
Balances as previously reported and effect of reverse recapitalization (880,710) $ 912 19,654,042 (77,841) (20,457,823) 0  
Beneficial conversion feature - convertible debenture 427,796   427,796        
Conversion of convertible debenture (in Shares)   544,178          
Conversion of convertible debenture 3,999,435 $ 54 3,999,381        
Repurchase of shares (in Shares)   (600,000)          
Repurchase of common stock from EDF (6,000,000) $ (60) (5,999,940)        
Assumption of private warrant liability from Newborn (1,253,228)   (1,253,228)        
Merger recapitalization, net of share redemption of issuance costs (in Shares)   8,060,418          
Merger recapitalization, net of share redemption of $18,629 and issuance costs of $5,979,675 51,751,363 $ 806 51,750,557        
Issuance of common shares (in Shares)   208,532          
Issuance of common shares 2,085,320 $ 21 2,085,299        
PIPE offering, less issuance costs (in Shares)   1,425,000          
PIPE offering, less issuance costs of $2,500 14,247,500 $ 143 14,247,357        
Proceeds from forward option put exercise (2,000,000)   (2,000,000)        
Stock-based compensation 262,105   262,105        
Currency translation adjustment 116,749     116,749      
Net loss (5,361,720)       (5,361,720)    
Balances (in Shares) at Mar. 31, 2021   18,761,124         0
Balance at Mar. 31, 2021 57,394,610 $ 1,876 83,173,369 38,908 (25,819,543) 0 $ 0
Balances (in Shares) at Dec. 31, 2020   26,162,122         16,789,088
Balances at Dec. 31, 2020 (880,710) $ 2,616 19,650,659 (77,841) (20,457,823) 0 $ 1,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Currency translation adjustment 147,782            
Net loss (18,517,308)            
Balances (in Shares) at Sep. 30, 2021   18,634,537         0
Balance at Sep. 30, 2021 88,950,334 $ 1,865 127,992,794 69,941 (38,844,294) (269,972) $ 0
Balances (in Shares) at Dec. 31, 2020   26,162,122         16,789,088
Balances at Dec. 31, 2020 (880,710) $ 2,616 19,650,659 (77,841) (20,457,823) 0 $ 1,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss 27,200,000            
Balances (in Shares) at Dec. 31, 2021   18,861,130          
Balance at Dec. 31, 2021 79,268,764 $ 1,888 127,138,504 113,446 (47,412,470) (572,604)  
Balances (in Shares) at Mar. 31, 2021   18,761,124         0
Balances at Mar. 31, 2021 57,394,610 $ 1,876 83,173,369 38,908 (25,819,543) 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Repurchase of shares (in Shares)   (134,500)          
Repurchase of common stock from EDF 0 $ (13) 13        
Issuance of common shares (in Shares)   0          
Issuance of common shares 0            
Stock-based compensation 1,090,603   1,090,603        
Additional merger recapitalization costs (265,736)   (265,736)        
Issuance of warrants to Stonepeak and Evolve 30,234,000   30,234,000        
Issuance of options to purchase shares of common stock to Stonepeak and Evolve 12,584,000   12,584,000        
Currency translation adjustment (20,146)     (20,146)      
Net loss (6,187,306)       (6,187,306)    
Balances (in Shares) at Jun. 30, 2021   18,626,624         0
Balance at Jun. 30, 2021 94,830,025 $ 1,863 126,816,249 18,762 (32,006,849) 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Proceeds from forward option put exercise (in Shares)   7,913          
Proceeds from forward option put exercise 18,325 $ 2 18,323        
Stock-based compensation 1,337,373   1,337,373        
Stonepeak and Evolve warrants and option deferred commitment costs - amortization (179,151)   (179,151)        
Currency translation adjustment 51,179     51,179      
Preferred dividends - non-controlling interest (39,096)         (39,096)  
Accretion on redeemable non-controlling interests preferred shares (100,039)         (100,039)  
Net loss (6,968,282)       (6,837,445) (130,837)  
Balances (in Shares) at Sep. 30, 2021   18,634,537         0
Balance at Sep. 30, 2021 88,950,334 $ 1,865 127,992,794 69,941 (38,844,294) (269,972) $ 0
Balances (in Shares) at Dec. 31, 2021   18,861,130          
Balances at Dec. 31, 2021 79,268,764 $ 1,888 127,138,504 113,446 (47,412,470) (572,604)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options and vesting of restricted stock (in shares)   (30,370)          
Exercise of stock options and vesting of restricted stock 3 $ 3          
Stock-based compensation 1,455,641   1,455,641        
Currency translation adjustment (13,684)     (13,684)      
Preferred dividends - non-controlling interest (64,015)         (64,015)  
Accretion on redeemable non-controlling interests preferred shares (161,466)         (161,466)  
Net loss (9,074,261)       (8,973,328) (100,933)  
Balances (in Shares) at Mar. 31, 2022   18,891,500          
Balance at Mar. 31, 2022 71,410,982 $ 1,891 128,594,145 99,762 (56,385,798) (899,018)  
Balances (in Shares) at Dec. 31, 2021   18,861,130          
Balances at Dec. 31, 2021 79,268,764 $ 1,888 127,138,504 113,446 (47,412,470) (572,604)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Currency translation adjustment (101,297)            
Net loss (70,773,374)            
Balances (in Shares) at Sep. 30, 2022   22,897,935          
Balance at Sep. 30, 2022 30,823,086 $ 2,292 150,247,403 12,149 (115,805,023) (3,633,735)  
Balances (in Shares) at Mar. 31, 2022   18,891,500          
Balances at Mar. 31, 2022 71,410,982 $ 1,891 128,594,145 99,762 (56,385,798) (899,018)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options and vesting of restricted stock (in shares)   (360,018)          
Exercise of stock options and vesting of restricted stock 173,625 $ 50 173,575        
Issuance of common shares (in Shares)   323,746          
Issuance of common shares 1,859,685 $ 32 1,859,653        
Proceeds from forward option put exercise (in Shares)   134,499          
Proceeds from forward option put exercise 1,994,072 $ 13 1,994,059        
Stock-based compensation 1,640,055   1,640,055        
Currency translation adjustment (26,314)     (26,314)      
Preferred dividends - non-controlling interest (65,296)         (65,296)  
Accretion on redeemable non-controlling interests preferred shares (161,466)         (161,466)  
Net loss (53,354,948)       (51,244,045) (2,110,903)  
Balances (in Shares) at Jun. 30, 2022   19,709,763          
Balance at Jun. 30, 2022 23,470,395 $ 1,986 134,261,487 73,448 (107,629,843) (3,236,683)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options and vesting of restricted stock (in shares)   (10,964)          
Exercise of stock options and vesting of restricted stock 35,703 $ (14) 35,717        
Issuance of common shares (in Shares)   469,136          
Issuance of common shares 1,903,811 $ 47 1,903,764        
Stock-based compensation 976,835   976,835        
Currency translation adjustment (61,299)     (61,299)      
Preferred dividends - non-controlling interest (66,601)         (66,601)  
Issuance of Common Shares related to Warrants (in shares)   580,000          
Issuance of Common Shares related to Warrants 58 $ 58          
Proceeds from Direct Offering (in shares)   2,150,000          
Proceeds from Direct Offering 13,069,815 $ 215 13,069,600        
Accretion on redeemable non-controlling interests preferred shares (161,466)         (161,466)  
Net loss (8,344,165)       (8,175,180) (168,985)  
Balances (in Shares) at Sep. 30, 2022   22,897,935          
Balance at Sep. 30, 2022 $ 30,823,086 $ 2,292 $ 150,247,403 $ 12,149 $ (115,805,023) $ (3,633,735)